About us
GrayMatters Health Overview
GrayMatters Health is a health technology company developing and marketing an interventional psychiatry suite powered by proprietary fMRI-Informed biomarkers. A growing community of behavioral health clinics across the US is building Prism programs for personalized patient care.
GrayMatters Health is the first company to develop digital brain region specific biomarkers for mental health. While medical biomarkers usually measure tissue to assess disease, our fMRI-Informed biomarkers measure brain activity associated with Depression and PTSD. These biomarkers were developed by harnessing advanced machine learning to register fMRI data from deep in the brain to readily accessible EEG. This innovation brings the power of evidence-based self-neuromodulation to any psychiatry clinic.
Founded in 2018 by Oded Kraft, Rani Cohen and Shai Attia, GrayMatters Health is on a mission to connect mental health disorders to their underlying brain mechanisms to improve patient care and outcomes. The company’s patented core technology was invented by Professor Talma Hendler, MD, PhD and her team at Tel Aviv University, with further development by GMH’s talented team of engineers.
The GrayMatters Health Team
Prof. Talma Hendler, MD, PhD
Inventor, SAB Chairperson,
Chief Medical Scientist
Oded Kraft
CEO, President
Co-founder
Rani Cohen
Executive Chairman BOD,
Co-founder
Shai Attia
VP R&D , Co-founder
Adar Shani
VP Clinical,
Regulatory & Quality Affairs
Dr. Aron Tendler
Chief Medical Officer
Kirk Thelander
Chief Commercial Officer
Pam Schwartz
VP Marketing
GrayMatters Health Awards
Best Startup Award 2023
GrayMatters Health Partners
